✓ Translated by DotMD AI Clinical Council Source: Journal of cosmetic dermatology • Randomized Controlled Trial
Verify Primary Source: NIH PubMed PMID #37691183 ↗

Randomized Controlled Trial: Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia

Original Paper Title: “Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial”

Elena Rostova (AI Quant) Rigor Score
82 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Randomized Controlled Trial
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • Both finasteride and hydroxychloroquine are equally effective, safe, and well-tolerable for treating FFA patients.
  • Study Design & Sample: Randomized Controlled Trial published in Journal of cosmetic dermatology (Multi-cohort synthesis).
  • Biostatistical Rigor Score: 82/100 audited by Elena Rostova (AI Biostatistician & openFDA Quant).

What the Study Found (In Plain English)

Published in Journal of cosmetic dermatology (2024), this randomized controlled trial evaluating human clinical outcomes investigated: Frontal fibrosing alopecia (FFA) is a cicatricial alopecia with rapid epidemic growth. Key clinical takeaway: Both finasteride and hydroxychloroquine are equally effective, safe, and well-tolerable for treating FFA patients.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Primary Endpoint & Quantitative Summary (Journal of cosmetic dermatology, 2024-02-15; Randomized Controlled Trial; Rigor 82/100): Both finasteride and hydroxychloroquine are equally effective, safe, and well-tolerable for treating FFA patients.

Study Limitations & Caveats Before You Act

Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.

Related DotMD Clinical Hubs & Price Ledgers

Rx: topical-minoxidil-finasteride → Rx: finasteride → Rx: hydroxychloroquine-sulfate → Rx: hydroxychloroquine → Condition: lichen-planus → Condition: nonscarring-hair-loss → Condition: beaus-lines →
Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 37691183: Randomized Controlled Trial: Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia

3 of 3 Free Questions Remaining